Kymera Therapeutics, Inc. ( KYMR) - Stock Earnings
KYMR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
KYMR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -87.0 million USD | 2.9 million USD |
| 2026Q1 | -69.2 million USD | 34.4 million USD |
| 2026Q2 | -61.2 million USD | 65.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KYMR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -147.0 million USD | 78.6 million USD |
| 2024 | -223.9 million USD | 47.1 million USD |
| 2025 | -311.4 million USD | 39.2 million USD |
| 2026 Est. | — | — |
KYMR
Price: $107.58
52 week price:
Earnings Per Share: -3.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 492600
Market Capitalization: 8.8 billion